Advertisement
Screener

ARTELO BIOSCIENCES, INC. (ARTL) Payments for (Proceeds from) Productive Assets

1.4 / 5 stars · 10/35 Roast Me

ARTELO BIOSCIENCES, INC. Payments for (Proceeds from) Productive Assets

ARTELO BIOSCIENCES, INC. (ARTL) reported Payments for (Proceeds from) Productive Assets of -$188.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.

Financial Statements › Cash Flow › Financing Activities

us-gaap:PaymentsForProceedsFromProductiveAssets · last filed 2026-02-24

  • ARTELO BIOSCIENCES, INC. payments for (proceeds from) productive assets for fiscal 2025 was -$188.00K.
  • ARTELO BIOSCIENCES, INC. payments for (proceeds from) productive assets for fiscal 2024 was $0.00.
Period endPayments for (Proceeds from) Productive Assets 12 month
2025-12-31-$188.00K
10-K · filed 2026-02-24
2024-12-31$0.00
10-K · filed 2026-02-24

Similar stocks

Stock NameCountryMarket CapPE Ratio
TherapeuticsMD, Inc. (TXMD)United States$0.024B-117.87
NextCure, Inc. (NXTC)United States$0.024B-0.15
Cocrystal Pharma, Inc. (COCP)United States$0.022B
AYTU BIOPHARMA, INC (AYTU)United States$0.025B-1.62
ATOSSA THERAPEUTICS, INC. (ATOS)United States$0.021B-0.52
Neuphoria Therapeutics Inc. (NEUP)United States$0.020B-1.77
Marker Therapeutics, Inc. (MRKR)United States$0.020B-2.86
Cellectar Biosciences, Inc. (CLRB)United States$0.020B-1.03
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
Rocket One Inc. (RKTO)United States$0.019B